X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17) 17
humans (13) 13
hemolytic-uremic syndrome (9) 9
immunology (9) 9
female (8) 8
activation (7) 7
alternative pathway (7) 7
complement (6) 6
complement system (6) 6
hemolytic uremic syndrome (6) 6
male (6) 6
mutations (6) 6
atypical hemolytic uremic syndrome (5) 5
child (5) 5
eculizumab (5) 5
urology & nephrology (5) 5
adolescent (4) 4
adult (4) 4
analysis (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
child, preschool (4) 4
complement activation (4) 4
escherichia-coli (4) 4
gene (4) 4
medicine & public health (4) 4
middle aged (4) 4
mutation (4) 4
proteins (4) 4
young adult (4) 4
abridged index medicus (3) 3
ahus (3) 3
atypical hemolytic uremic syndrome - drug therapy (3) 3
atypical hemolytic uremic syndrome - immunology (3) 3
biochemistry & molecular biology (3) 3
c3 glomerulopathy (3) 3
case-control studies (3) 3
complement activation - immunology (3) 3
complement component c3 (3) 3
complement inactivating agents - therapeutic use (3) 3
complement system proteins - genetics (3) 3
dense deposit disease (3) 3
disease (3) 3
factor-h (3) 3
factor-h autoantibodies (3) 3
factor-i (3) 3
gain (3) 3
genetics & heredity (3) 3
hemolytic-uremic syndrome - genetics (3) 3
identification (3) 3
infant (3) 3
kidney diseases (3) 3
original (3) 3
pathway c3 convertase (3) 3
predispose (3) 3
thrombotic microangiopathy (3) 3
alleles (2) 2
animals (2) 2
article (2) 2
atypical hemolytic uremic syndrome - blood (2) 2
atypical hemolytic uremic syndrome - pathology (2) 2
atypical hus (2) 2
autoantibodies - immunology (2) 2
bacterial outer membrane proteins - genetics (2) 2
bacterial outer membrane proteins - metabolism (2) 2
basic medicine (2) 2
c3 mutation (2) 2
care and treatment (2) 2
cell biology (2) 2
cells (2) 2
children (2) 2
complement activation - drug effects (2) 2
complement c3b - metabolism (2) 2
complement c5a - immunology (2) 2
complement factor b - genetics (2) 2
complement factor h (2) 2
complement factor h - genetics (2) 2
complement inhibitor eculizumab (2) 2
complement membrane attack complex - metabolism (2) 2
complement regulation (2) 2
complement system proteins - immunology (2) 2
convertase (2) 2
crystal-structure (2) 2
decay-accelerating factor (2) 2
diagnosis (2) 2
discontinuation (2) 2
dose-response relationship, drug (2) 2
efficacy (2) 2
enzyme-linked immunosorbent assay (2) 2
factor-b (2) 2
gene frequency (2) 2
genetic aspects (2) 2
genetic defects (2) 2
hemic and lymphatic diseases (2) 2
in-vitro (2) 2
infections (2) 2
klinisk medisinske fag: 750 (2) 2
mcp (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
medicinska och farmaceutiska grundvetenskaper (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nephrology, Dialysis, Transplantation, ISSN 0931-0509, 2018, Volume 33, Issue 4, pp. 635 - 645
Background. Atypical haemolytic uremic syndrome (aHUS) is a rare but severe form of thrombotic microangiopathy as a consequence of complement dysregulation.... 
eculizumab | thrombotic microangiopathy | atypical haemolytic uremic syndrome | complement | restrictive therapy | MAINTENANCE TREATMENT | COMPLEMENT ACTIVATION | DISCONTINUATION | CHILDREN | TRANSPLANTATION | THERAPY | KIDNEY-TRANSPLANTATION | UROLOGY & NEPHROLOGY | UPDATE | AHUS | MUTATIONS | GAIN
Journal Article
Kidney International, ISSN 0085-2538, 04/2019, Volume 95, Issue 4, pp. 996 - 996
Journal Article
Journal Article
Journal Article
Journal Article
Molecular Immunology, ISSN 0161-5890, 09/2017, Volume 89, pp. 111 - 114
•Antibodies to neoepitopes are crucial tools for detection of complement activation.•Changes of complement proteins without activation can expose... 
Eculizumab | C5 | Neoepitope | Complement | C5a | ACTIVATION | OXYGEN RADICALS | BIOCHEMISTRY & MOLECULAR BIOLOGY | 5TH | MONOCLONAL-ANTIBODY | C5B-LIKE C5 | IMMUNOLOGY | CLEAVAGE | INHIBITOR ECULIZUMAB | GENERATION | Epitopes - metabolism | Immunoglobulin G - blood | Outcome Assessment (Health Care) | Complement C5b - immunology | Humans | Complement C5a - metabolism | Atypical Hemolytic Uremic Syndrome - immunology | Complement C5b - metabolism | Complement Activation - immunology | Epitopes - immunology | Hemoglobinuria, Paroxysmal - immunology | Immunoglobulin G - immunology | Complement C5 - immunology | Atypical Hemolytic Uremic Syndrome - drug therapy | Hemoglobinuria, Paroxysmal - blood | Complement Activation - drug effects | Complement Inactivating Agents - metabolism | Antibodies, Monoclonal, Humanized - therapeutic use | Complement C5 - metabolism | Enzyme-Linked Immunosorbent Assay | Antibodies, Monoclonal, Humanized - metabolism | Protein Binding - immunology | Complement Inactivating Agents - therapeutic use | Hemoglobinuria, Paroxysmal - drug therapy | Complement C5a - immunology | Chromatography, Gel | Atypical Hemolytic Uremic Syndrome - blood | Hydrogen-Ion Concentration | Proteins | Monoclonal antibodies | Biological products | Drug approval | Analysis | VDP | Medisinske Fag: 700 | Klinisk medisinske fag: 750 | Hematologi: 775 | Biological Sciences | Immunology | Naturvetenskap | Immunologi | Biologiska vetenskaper | Natural Sciences
Journal Article